Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study
The management of patients with acute pancreatitis is complicated by the inability to distinguish mild from severe disease during the early stages. It has been previously shown that urinary trypsinogen activation peptide (TAP) and hematocrit (Hct) may serve as early predictors of severity in patient...
Gespeichert in:
Veröffentlicht in: | The American journal of gastroenterology 2002-08, Vol.97 (8), p.1973-1977 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1977 |
---|---|
container_issue | 8 |
container_start_page | 1973 |
container_title | The American journal of gastroenterology |
container_volume | 97 |
creator | Khan, Zia Vlodov, Jane Horovitz, Joel Jose, Rose Mary Iswara, K. Smotkin, Joseph Brown, Alphonso Tenner, Scott |
description | The management of patients with acute pancreatitis is complicated by the inability to distinguish mild from severe disease during the early stages. It has been previously shown that urinary trypsinogen activation peptide (TAP) and hematocrit (Hct) may serve as early predictors of severity in patients with acute pancreatitis. To establish which marker is more accurate in the determination of severity in patients with acute pancreatitis, a prospective study was performed. A consecutive series of patients admitted with pain consistent with acute pancreatitis and an amylase of three times the upper limit of normal were included. The admission and 24-h Hct was obtained. A urine sample was obtained within 12 h of admission. Urinary TAP was determined using a modified solid phase ELISA. Severity was defined by the Atlanta Symposium, as the presence of organ failure and/or pancreatic necrosis. Fifty-eight consecutive patients with acute pancreatitis participated. There were 33 men and 25 women with a mean age of 60 ± 19. Thirty-nine patients had mild disease; 19 had severe disease. Urinary TAP was elevated in 26 patients. All patients with severe pancreatitis were correctly identified as having severe disease by an elevated urinary TAP (sensitivity 100%, specificity 77%). The admission Hct was higher than 47 in only three patients, all with mild disease. Of the patients with a rise in Hct, eight had mild disease, and only one had severe disease. Using a Hct of 44 as a cutoff did not affect the accuracy. There was no association between a rise in Hct and failure of Hct to decrease in the determination of severity. In comparison to admission Hct, urinary TAP was more accurate in determining severity in patients with acute pancreatitis by Atlanta, APACHE II, and Ranson criteria. We conclude that urinary TAP is a more accurate predictor of severity in patients with acute pancreatitis compared with Hct. Urinary TAP should be used to determine severity in patients early in the course of acute pancreatitis. |
doi_str_mv | 10.1111/j.1572-0241.2002.05953.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72021448</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4033704511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3714-175eefd6e24e367cdf09af15d549d1527b0a6176a6c228c19c1e0ddb5662bce63</originalsourceid><addsrcrecordid>eNpdUstu1DAUtRCIDoVfQJYQ7BL8ipOwQ1WhlSqxoWvL49xMPCROsJ1O50_4XGxm1Ep4Y_nec859HCOEKSlpOp_3Ja1qVhAmaMkIYSWp2oqXjy_Q5inxEm1IShUtq8kFehPCnhBasbp6jS4ooy2hkm_Qn3tvnfZHHP1xCdbNO3BYm2gfdLSzwwss0XaAbcDT7CGlzOp1BBwH7fAAk46z8TZi63AHEfxknXU7HOABUviY40uSAhcDPtg4JIU10RftjIeUiDZ8wRovfg4L5LqAQ1y741v0qtdjgHfn-xLdf7v-eXVT3P34fnv19a4wvKaioHUF0HcSmAAua9P1pNU9rbpKtF0ed0u0pLXU0jDWGNoaCqTrtpWUbGtA8kv06aSbOvi9QohqssHAOGoH8xpUzQijQjQJ-OE_4H5evUu9KVo3vOWEyCzXnFAmDRQ89GrxdkoLVpSo7J3aq2yRyhap7J365516TNT35wLrdoLumXg2KwE-ngE6GD32Pu3QhmccbwRvWe5UnHCHeUyOhF_jegCvBtBjHBTJR3BR5OKkSY8i_xORaPhEczquHp509X6XoRUV_C_a_cCs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1783930066</pqid></control><display><type>article</type><title>Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Khan, Zia ; Vlodov, Jane ; Horovitz, Joel ; Jose, Rose Mary ; Iswara, K. ; Smotkin, Joseph ; Brown, Alphonso ; Tenner, Scott</creator><creatorcontrib>Khan, Zia ; Vlodov, Jane ; Horovitz, Joel ; Jose, Rose Mary ; Iswara, K. ; Smotkin, Joseph ; Brown, Alphonso ; Tenner, Scott</creatorcontrib><description>The management of patients with acute pancreatitis is complicated by the inability to distinguish mild from severe disease during the early stages. It has been previously shown that urinary trypsinogen activation peptide (TAP) and hematocrit (Hct) may serve as early predictors of severity in patients with acute pancreatitis. To establish which marker is more accurate in the determination of severity in patients with acute pancreatitis, a prospective study was performed. A consecutive series of patients admitted with pain consistent with acute pancreatitis and an amylase of three times the upper limit of normal were included. The admission and 24-h Hct was obtained. A urine sample was obtained within 12 h of admission. Urinary TAP was determined using a modified solid phase ELISA. Severity was defined by the Atlanta Symposium, as the presence of organ failure and/or pancreatic necrosis. Fifty-eight consecutive patients with acute pancreatitis participated. There were 33 men and 25 women with a mean age of 60 ± 19. Thirty-nine patients had mild disease; 19 had severe disease. Urinary TAP was elevated in 26 patients. All patients with severe pancreatitis were correctly identified as having severe disease by an elevated urinary TAP (sensitivity 100%, specificity 77%). The admission Hct was higher than 47 in only three patients, all with mild disease. Of the patients with a rise in Hct, eight had mild disease, and only one had severe disease. Using a Hct of 44 as a cutoff did not affect the accuracy. There was no association between a rise in Hct and failure of Hct to decrease in the determination of severity. In comparison to admission Hct, urinary TAP was more accurate in determining severity in patients with acute pancreatitis by Atlanta, APACHE II, and Ranson criteria. We conclude that urinary TAP is a more accurate predictor of severity in patients with acute pancreatitis compared with Hct. Urinary TAP should be used to determine severity in patients early in the course of acute pancreatitis.</description><identifier>ISSN: 0002-9270</identifier><identifier>EISSN: 1572-0241</identifier><identifier>DOI: 10.1111/j.1572-0241.2002.05953.x</identifier><identifier>PMID: 12190163</identifier><language>eng</language><publisher>Oxford: .</publisher><subject>Acute Disease ; Biological and medical sciences ; Biomarkers - urine ; Chi-Square Distribution ; Digestive system ; Enzyme-Linked Immunosorbent Assay ; Female ; Gastroenterology ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Medical sciences ; Middle Aged ; Oligopeptides - urine ; Pancreatitis - diagnosis ; Pancreatitis - enzymology ; Pancreatitis - urine ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Predictive Value of Tests ; Prognosis ; Severity of Illness Index</subject><ispartof>The American journal of gastroenterology, 2002-08, Vol.97 (8), p.1973-1977</ispartof><rights>All Rights Reserved.</rights><rights>2002 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Aug 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3714-175eefd6e24e367cdf09af15d549d1527b0a6176a6c228c19c1e0ddb5662bce63</citedby><cites>FETCH-LOGICAL-c3714-175eefd6e24e367cdf09af15d549d1527b0a6176a6c228c19c1e0ddb5662bce63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13843928$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12190163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Zia</creatorcontrib><creatorcontrib>Vlodov, Jane</creatorcontrib><creatorcontrib>Horovitz, Joel</creatorcontrib><creatorcontrib>Jose, Rose Mary</creatorcontrib><creatorcontrib>Iswara, K.</creatorcontrib><creatorcontrib>Smotkin, Joseph</creatorcontrib><creatorcontrib>Brown, Alphonso</creatorcontrib><creatorcontrib>Tenner, Scott</creatorcontrib><title>Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study</title><title>The American journal of gastroenterology</title><addtitle>Am J Gastroenterol</addtitle><description>The management of patients with acute pancreatitis is complicated by the inability to distinguish mild from severe disease during the early stages. It has been previously shown that urinary trypsinogen activation peptide (TAP) and hematocrit (Hct) may serve as early predictors of severity in patients with acute pancreatitis. To establish which marker is more accurate in the determination of severity in patients with acute pancreatitis, a prospective study was performed. A consecutive series of patients admitted with pain consistent with acute pancreatitis and an amylase of three times the upper limit of normal were included. The admission and 24-h Hct was obtained. A urine sample was obtained within 12 h of admission. Urinary TAP was determined using a modified solid phase ELISA. Severity was defined by the Atlanta Symposium, as the presence of organ failure and/or pancreatic necrosis. Fifty-eight consecutive patients with acute pancreatitis participated. There were 33 men and 25 women with a mean age of 60 ± 19. Thirty-nine patients had mild disease; 19 had severe disease. Urinary TAP was elevated in 26 patients. All patients with severe pancreatitis were correctly identified as having severe disease by an elevated urinary TAP (sensitivity 100%, specificity 77%). The admission Hct was higher than 47 in only three patients, all with mild disease. Of the patients with a rise in Hct, eight had mild disease, and only one had severe disease. Using a Hct of 44 as a cutoff did not affect the accuracy. There was no association between a rise in Hct and failure of Hct to decrease in the determination of severity. In comparison to admission Hct, urinary TAP was more accurate in determining severity in patients with acute pancreatitis by Atlanta, APACHE II, and Ranson criteria. We conclude that urinary TAP is a more accurate predictor of severity in patients with acute pancreatitis compared with Hct. Urinary TAP should be used to determine severity in patients early in the course of acute pancreatitis.</description><subject>Acute Disease</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - urine</subject><subject>Chi-Square Distribution</subject><subject>Digestive system</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Oligopeptides - urine</subject><subject>Pancreatitis - diagnosis</subject><subject>Pancreatitis - enzymology</subject><subject>Pancreatitis - urine</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Severity of Illness Index</subject><issn>0002-9270</issn><issn>1572-0241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdUstu1DAUtRCIDoVfQJYQ7BL8ipOwQ1WhlSqxoWvL49xMPCROsJ1O50_4XGxm1Ep4Y_nec859HCOEKSlpOp_3Ja1qVhAmaMkIYSWp2oqXjy_Q5inxEm1IShUtq8kFehPCnhBasbp6jS4ooy2hkm_Qn3tvnfZHHP1xCdbNO3BYm2gfdLSzwwss0XaAbcDT7CGlzOp1BBwH7fAAk46z8TZi63AHEfxknXU7HOABUviY40uSAhcDPtg4JIU10RftjIeUiDZ8wRovfg4L5LqAQ1y741v0qtdjgHfn-xLdf7v-eXVT3P34fnv19a4wvKaioHUF0HcSmAAua9P1pNU9rbpKtF0ed0u0pLXU0jDWGNoaCqTrtpWUbGtA8kv06aSbOvi9QohqssHAOGoH8xpUzQijQjQJ-OE_4H5evUu9KVo3vOWEyCzXnFAmDRQ89GrxdkoLVpSo7J3aq2yRyhap7J365516TNT35wLrdoLumXg2KwE-ngE6GD32Pu3QhmccbwRvWe5UnHCHeUyOhF_jegCvBtBjHBTJR3BR5OKkSY8i_xORaPhEczquHp509X6XoRUV_C_a_cCs</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Khan, Zia</creator><creator>Vlodov, Jane</creator><creator>Horovitz, Joel</creator><creator>Jose, Rose Mary</creator><creator>Iswara, K.</creator><creator>Smotkin, Joseph</creator><creator>Brown, Alphonso</creator><creator>Tenner, Scott</creator><general>.</general><general>Blackwell Publishing</general><general>Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>20020801</creationdate><title>Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study</title><author>Khan, Zia ; Vlodov, Jane ; Horovitz, Joel ; Jose, Rose Mary ; Iswara, K. ; Smotkin, Joseph ; Brown, Alphonso ; Tenner, Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3714-175eefd6e24e367cdf09af15d549d1527b0a6176a6c228c19c1e0ddb5662bce63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acute Disease</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - urine</topic><topic>Chi-Square Distribution</topic><topic>Digestive system</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Oligopeptides - urine</topic><topic>Pancreatitis - diagnosis</topic><topic>Pancreatitis - enzymology</topic><topic>Pancreatitis - urine</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Zia</creatorcontrib><creatorcontrib>Vlodov, Jane</creatorcontrib><creatorcontrib>Horovitz, Joel</creatorcontrib><creatorcontrib>Jose, Rose Mary</creatorcontrib><creatorcontrib>Iswara, K.</creatorcontrib><creatorcontrib>Smotkin, Joseph</creatorcontrib><creatorcontrib>Brown, Alphonso</creatorcontrib><creatorcontrib>Tenner, Scott</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>The American journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Zia</au><au>Vlodov, Jane</au><au>Horovitz, Joel</au><au>Jose, Rose Mary</au><au>Iswara, K.</au><au>Smotkin, Joseph</au><au>Brown, Alphonso</au><au>Tenner, Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study</atitle><jtitle>The American journal of gastroenterology</jtitle><addtitle>Am J Gastroenterol</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>97</volume><issue>8</issue><spage>1973</spage><epage>1977</epage><pages>1973-1977</pages><issn>0002-9270</issn><eissn>1572-0241</eissn><abstract>The management of patients with acute pancreatitis is complicated by the inability to distinguish mild from severe disease during the early stages. It has been previously shown that urinary trypsinogen activation peptide (TAP) and hematocrit (Hct) may serve as early predictors of severity in patients with acute pancreatitis. To establish which marker is more accurate in the determination of severity in patients with acute pancreatitis, a prospective study was performed. A consecutive series of patients admitted with pain consistent with acute pancreatitis and an amylase of three times the upper limit of normal were included. The admission and 24-h Hct was obtained. A urine sample was obtained within 12 h of admission. Urinary TAP was determined using a modified solid phase ELISA. Severity was defined by the Atlanta Symposium, as the presence of organ failure and/or pancreatic necrosis. Fifty-eight consecutive patients with acute pancreatitis participated. There were 33 men and 25 women with a mean age of 60 ± 19. Thirty-nine patients had mild disease; 19 had severe disease. Urinary TAP was elevated in 26 patients. All patients with severe pancreatitis were correctly identified as having severe disease by an elevated urinary TAP (sensitivity 100%, specificity 77%). The admission Hct was higher than 47 in only three patients, all with mild disease. Of the patients with a rise in Hct, eight had mild disease, and only one had severe disease. Using a Hct of 44 as a cutoff did not affect the accuracy. There was no association between a rise in Hct and failure of Hct to decrease in the determination of severity. In comparison to admission Hct, urinary TAP was more accurate in determining severity in patients with acute pancreatitis by Atlanta, APACHE II, and Ranson criteria. We conclude that urinary TAP is a more accurate predictor of severity in patients with acute pancreatitis compared with Hct. Urinary TAP should be used to determine severity in patients early in the course of acute pancreatitis.</abstract><cop>Oxford</cop><pub>.</pub><pmid>12190163</pmid><doi>10.1111/j.1572-0241.2002.05953.x</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9270 |
ispartof | The American journal of gastroenterology, 2002-08, Vol.97 (8), p.1973-1977 |
issn | 0002-9270 1572-0241 |
language | eng |
recordid | cdi_proquest_miscellaneous_72021448 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Acute Disease Biological and medical sciences Biomarkers - urine Chi-Square Distribution Digestive system Enzyme-Linked Immunosorbent Assay Female Gastroenterology Humans Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Oligopeptides - urine Pancreatitis - diagnosis Pancreatitis - enzymology Pancreatitis - urine Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Predictive Value of Tests Prognosis Severity of Illness Index |
title | Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A08%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urinary%20trypsinogen%20activation%20peptide%20is%20more%20accurate%20than%20hematocrit%20in%20determining%20severity%20in%20patients%20with%20acute%20pancreatitis:%20a%20prospective%20study&rft.jtitle=The%20American%20journal%20of%20gastroenterology&rft.au=Khan,%20Zia&rft.date=2002-08-01&rft.volume=97&rft.issue=8&rft.spage=1973&rft.epage=1977&rft.pages=1973-1977&rft.issn=0002-9270&rft.eissn=1572-0241&rft_id=info:doi/10.1111/j.1572-0241.2002.05953.x&rft_dat=%3Cproquest_cross%3E4033704511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1783930066&rft_id=info:pmid/12190163&rfr_iscdi=true |